KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Net Income (2016 - 2025)

Historic Net Income for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $128.2 million.

  • West Pharmaceutical Services' Net Income rose 7.81% to $128.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $479.3 million, marking a year-over-year increase of 27.2%. This contributed to the annual value of $479.3 million for FY2025, which is 27.2% up from last year.
  • According to the latest figures from Q4 2025, West Pharmaceutical Services' Net Income is $128.2 million, which was up 7.81% from $137.9 million recorded in Q3 2025.
  • West Pharmaceutical Services' 5-year Net Income high stood at $183.0 million for Q2 2022, and its period low was $86.4 million during Q1 2025.
  • In the last 5 years, West Pharmaceutical Services' Net Income had a median value of $134.0 million in 2023 and averaged $137.0 million.
  • In the last 5 years, West Pharmaceutical Services' Net Income surged by 12075.72% in 2021 and then crashed by 3243.06% in 2022.
  • Quarter analysis of 5 years shows West Pharmaceutical Services' Net Income stood at $147.7 million in 2021, then crashed by 32.43% to $99.8 million in 2022, then skyrocketed by 33.97% to $133.7 million in 2023, then fell by 4.19% to $128.1 million in 2024, then increased by 0.08% to $128.2 million in 2025.
  • Its last three reported values are $128.2 million in Q4 2025, $137.9 million for Q3 2025, and $126.8 million during Q2 2025.